US 7662999
Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases
granted A61PA61P31/04A61P37/02
Quick answer
US patent 7662999 (Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases) held by The United States of America as represented by the Department of Health and Human Services (DHHS) expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Department of Health and Human Services (DHHS)
- Grant date
- Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P31/04, A61P37/02, A61P43/00